Royal Bank of Canada
CRL icon

Royal Bank of Canada’s Charles River Laboratories CRL Stock Holding History

Royal Bank of Canada’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-11,400
Closed -$2.85M – 7464
2020
Q4 		$2.85M Buy
+11,400
New +$2.72M ﹤0.01% 2609

Other funds holding CRL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Royal Bank of Canada's CRL Position: Q1 2026 in Review

Royal Bank of Canada reduced its Charles River Laboratories (CRL) stake by 19% in Q1 2026, selling an estimated $4.33M and leaving 100,311 shares worth $17.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1545.

Royal Bank of Canada first reported a position in CRL in Q2 2013 and has held it in 52 quarters since. The position peaked at $297M in Q3 2021. 558 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Royal Bank of Canada held 100,311 shares of Charles River Laboratories worth $17.3M as of Q1 2026.
  • Royal Bank of Canada sold 23,345 Charles River Laboratories shares in Q1 2026, an estimated $4.33M.
  • Charles River Laboratories made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #1545 holding.
  • Royal Bank of Canada first reported a position in Charles River Laboratories in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Charles River Laboratories position peaked at $297M in Q3 2021.
  • 558 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.